Articles related to GLAUCOMA

A case-control study identified covert mortality nodavirus, previously known only in aquatic animals, in iris tissue of patients with persistent ocular hypertensive viral anterior uveitis, with exposure risk concentrated among those who handle or consume raw aquatic animals daily.

Bayer agreed to acquire Perfuse Therapeutics in a deal valued at up to $2.45 billion, gaining full rights to a phase 2 endothelin receptor antagonist for glaucoma and diabetic retinopathy.

“In discussions with ophthalmologists and optometrists, nearly all say they would choose SLT first if it were their own eye. However, when asked how often their patients receive SLT as initial therapy, most report rates around 10%.” – John Berdahl, MD, Vance Thompson Vision

“Despite more than 100 years of lowering intraocular pressure… too many patients still go blind.” — Eugene de Juan Jr, MD, UCSF

Blake Williamson, MD, MPH, MS, demonstrates femtosecond laser assisted cataract surgery (FLACS) with a toric lens and iStent inject.

This study examination reveals that lower body weight is a significant general morphological indicator associated with primary angle-closure glaucoma (PACG). This finding underscores the importance of considering patient’s physical characteristics in managing PACG.